Related references
Note: Only part of the references are listed.Efavirenz and Metabolites in Cerebrospinal Fluid: Relationship with CYP2B6 c.516G→T Genotype and Perturbed Blood-Brain Barrier Due to Tuberculous Meningitis
Sam Nightingale et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Antiretroviral Treatment with Efavirenz Disrupts the Blood-Brain Barrier Integrity and Increases Stroke Severity
Luc Bertrand et al.
SCIENTIFIC REPORTS (2016)
Breast Milk Pharmacokinetics of Efavirenz and Breastfed Infants' Exposure in Genetically Defined Subgroups of Mother-Infant Pairs: An Observational Study
Adeniyi Olagunju et al.
CLINICAL INFECTIOUS DISEASES (2015)
Rhodamine/Nanodiamond as a System Model for Drug Carrier
G. Reina et al.
JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY (2015)
Functionalized Nanodiamonds for Biological and Medical Applications
Lin Lai et al.
JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY (2015)
The potential of HIV-1 nanotherapeutics: from in vitro studies to clinical trials
Upal Roy et al.
NANOMEDICINE (2015)
DJ1 expression downregulates in neuroblastoma cells (SK-N-MC) chronically exposed to HIV-1 and cocaine
Upal Roy et al.
FRONTIERS IN MICROBIOLOGY (2015)
CYP2B6*6, CYP2B6*18, Body weight and sex are predictors of efavirenz pharmacokinetics and treatment response: population pharmacokinetic modeling in an HIV/AIDS and TB cohort in Zimbabwe
Milcah Dhoro et al.
BMC PHARMACOLOGY & TOXICOLOGY (2015)
Synthesis of nanodiamond derivatives carrying amino functions and quantification by a modified Kaiser test
Gerald Jarre et al.
BEILSTEIN JOURNAL OF ORGANIC CHEMISTRY (2014)
Immunoneuropathogenesis of HIV-1 clades B and C: Role of redox expression and thiol modification
Thangavel Samikkannu et al.
FREE RADICAL BIOLOGY AND MEDICINE (2014)
Dose reduction of efavirenz: an observational study describing cost-effectiveness, pharmacokinetics and pharmacogenetics
Almudena Sanchez Martin et al.
PHARMACOGENOMICS (2014)
Vorinostat positively regulates synaptic plasticity genes expression and spine density in HIV infected neurons: role of nicotine in progression of HIV-associated neurocognitive disorder
Venkata Subba Rao Atluri et al.
MOLECULAR BRAIN (2014)
Adsorption of Drugs on Nanodiamond: Toward Development of a Drug Delivery Platform
Vadym N. Mochalin et al.
MOLECULAR PHARMACEUTICS (2013)
Human Synaptic Plasticity Gene Expression Profile and Dendritic Spine Density Changes in HIV-Infected Human CNS Cells: Role in HIV-Associated Neurocognitive Disorders (HAND)
Venkata Subba Rao Atluri et al.
PLOS ONE (2013)
Nanodiamonds as Platforms for Biology and Medicine
Han B. Man et al.
JALA (2013)
Functionality is Key: Recent Progress in the Surface Modification of Nanodiamond
Anke Krueger et al.
ADVANCED FUNCTIONAL MATERIALS (2012)
HIV reservoirs: pathogenesis and obstacles to viral eradication and cure
Tae-Wook Chun et al.
AIDS (2012)
Multiscale Simulation as a Framework for the Enhanced Design of Nanodiamond-Polyethylenimine-Based Gene Delivery
Hansung Kim et al.
JOURNAL OF PHYSICAL CHEMISTRY LETTERS (2012)
The properties and applications of nanodiamonds
Vadym N. Mochalin et al.
NATURE NANOTECHNOLOGY (2012)
Preventing Pandemics Via International Development: A Systems Approach
Tiffany L. Bogich et al.
PLOS MEDICINE (2012)
Facile fabrication of HDPE-g-MA/nanodiamond nanocomposites via one-step reactive blending
Ping'an Song et al.
NANOSCALE RESEARCH LETTERS (2012)
UPLC-MS/MS quantification of nanoformulated ritonavir, indinavir, atazanavir, and efavirenz in mouse serum and tissues
Jiangeng Huang et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2011)
Nanodiamonds as Carriers for Address Delivery of Biologically Active Substances
K. V. Purtov et al.
NANOSCALE RESEARCH LETTERS (2010)
Nanodiamond-insulin complexes as pH-dependent protein delivery vehicles
Rafael A. Shimkunas et al.
BIOMATERIALS (2009)
Contribution of Functional Groups to the Raman Spectrum of Nanodiamond Powders
Vadym Mochalin et al.
CHEMISTRY OF MATERIALS (2009)
Ultrananocrystalline Diamond Thin Films Functionalized with Therapeutically Active Collagen Networks
Houjin Huang et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2009)
PEGylated nanographene oxide for delivery of water-insoluble cancer drugs
Zhuang Liu et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
Active nanodiamond hydrogels for chemotherapeutic delivery
Houjin Huang et al.
NANO LETTERS (2007)
Biocompatible and detectable carboxylated nanodiamond on human cell
Kuang-Kai Liu et al.
NANOTECHNOLOGY (2007)
Are diamond nanoparticles cytotoxic?
Amanda M. Schrand et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2007)
Carbon nanotubes as nanomedicines: From toxicology to pharmacology
Lara Lacerda et al.
ADVANCED DRUG DELIVERY REVIEWS (2006)
Control of sp2/sp3 carbon ratio and surface chemistry of nanodiamond powders by selective oxidation in air
Sebastian Osswald et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2006)
The assessment of cognitive function in advanced HIV-1 infection and AIDS dementia complex using a new computerised cognitive test battery
LAJ Cysique et al.
ARCHIVES OF CLINICAL NEUROPSYCHOLOGY (2006)
Neoadjuvant percutaneous 4-hydroxytamoxifen decreases breast tumoral cell proliferation: A prospective controlled randomized study comparing three doses of 4-hydroxytamoxifen gel to oral tamoxifen
P Rouanet et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Cellular effects of purvalanol A: A specific inhibitor of cyclin-dependent kinase activities
N Villerbu et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Design and gene delivery activity of modified polyethylenimines
R Kircheis et al.
ADVANCED DRUG DELIVERY REVIEWS (2001)
Clinical trials in HIV-associated cognitive impairment: Cognitive and functional outcomes
G Schifitto et al.
NEUROLOGY (2001)
Share Paper
